| Financial Year |
March 31 2023 |
| Monetary Funds |
905,098,479.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
726,253,846.57 |
| Accounts Receivable |
1,106,916,336.38 |
| Advances to Suppliers |
248,000,088.42 |
| Other Receivables |
113,911,224.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
803,750,841.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,783,532.76 |
| Total Current Assets |
4,318,622,788.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,965,232,075.78 |
| Under-construction Projects |
1,033,801,233.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
710,348,852.19 |
| R&D expenses |
16,500,540.94 |
| Goodwill |
17,583,473.33 |
| Long-Term Deferred and Prepaid Expenses |
1,179,095.75 |
| Deferred Income Tax Assets |
16,390,724.00 |
| Other Non-Current Assets |
935,184,083.53 |
| Sub-Total of Non-Current Assets |
6,708,408,318.07 |
| Total Assets |
11,027,031,106.24 |
| Short-Term Loans |
1,339,003,599.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
435,712,537.47 |
| Accounts Payable |
1,516,363,478.03 |
| Accounts Received In Advance |
191,227.26 |
| Employee Compensation Payable |
27,979,014.39 |
| Taxes Payable |
20,025,856.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
247,010,275.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
68,244,552.85 |
| Other Current Liabilities |
229,012,680.35 |
| Sub-Total of Current Liabilities |
3,966,159,360.02 |
| Long-term Loans |
2,319,555,870.66 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
40,568,717.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,425,439,695.00 |
| Total Liabilities |
6,391,599,055.02 |
| Paid-In Capital(Or Share Stock) |
645,674,963.00 |
| Capital Surplus |
3,780,818,962.41 |
| Surplus Reserve |
51,365,509.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-232,982,323.23 |
| Minority Stockholder's Interest |
390,554,940.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,244,877,111.22 |
| Owner's Equity（Stockholder's Equity） |
4,635,432,051.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,027,031,106.24 |
